These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1863470)

  • 21. Rapid and simple purification of human immunodeficiency virus 1 epitope gp41.
    Sohn MJ; Cho SH; Jang WH; Chong YH; Nham SU; Lee YI
    J Virol Methods; 1993 Jan; 41(1):93-100. PubMed ID: 7679396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fine mapping of an immunodominant region of the transmembrane protein of the human immunodeficiency virus (HIV-1).
    Döpel SH; Porstmann T; Henklein P; von Baehr R
    J Virol Methods; 1989 Aug; 25(2):167-77. PubMed ID: 2476460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant proteins derived from immunodominant regions of the gag and env genes of HIV-1 and their potential for use in serologic diagnosis.
    Kovác J
    Acta Virol; 1991 Aug; 35(4):383-90. PubMed ID: 1686963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of a chimera HIV-1/HIV-2 envelope protein for immunodiagnosis of HIV infection: its expression and purification in E. coli by use of a translation initiation site within HIV-1 env gene.
    Han B; Meng L; Song X; Chen Q; Wang H; Ling S; Ma X
    Biochem Mol Biol Int; 1998 Oct; 46(3):607-17. PubMed ID: 9818100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of fusion peptide or destabilization of fusion core of HIV gp41 enhances antigenicity and immunogenicity of 4E10 epitope.
    Li J; Chen X; Jiang S; Chen YH
    Biochem Biophys Res Commun; 2008 Nov; 376(1):60-4. PubMed ID: 18762167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope.
    Palacios-Rodríguez Y; Gazarian T; Rowley M; Majluf-Cruz A; Gazarian K
    J Microbiol Methods; 2007 Feb; 68(2):225-35. PubMed ID: 17046088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.
    Horal P; Svennerholm B; Jeansson S; Rymo L; Hall WW; Vahlne A
    J Virol; 1991 May; 65(5):2718-23. PubMed ID: 1707985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.
    Oldstone MB; Tishon A; Lewicki H; Dyson HJ; Feher VA; Assa-Munt N; Wright PE
    J Virol; 1991 Apr; 65(4):1727-34. PubMed ID: 2002540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.
    Xu JY; Gorny MK; Palker T; Karwowska S; Zolla-Pazner S
    J Virol; 1991 Sep; 65(9):4832-8. PubMed ID: 1714520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of multiple antigenic peptide (MAP) in the immunodiagnosis of human immunodeficiency virus infection.
    Shin SY; Lee MK; Kim SY; Jang SY; Hahm KS
    Biochem Mol Biol Int; 1997 Nov; 43(4):713-21. PubMed ID: 9385431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera.
    Vella C; Ferguson M; Dunn G; Meloen R; Langedijk H; Evans D; Minor PD
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2603-7. PubMed ID: 7506299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].
    Isaguliants MG; Koshida R; Ruden U; Varen B
    Biokhimiia; 1996 Jul; 61(7):1221-9. PubMed ID: 9035735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.
    Calarota S; Jansson M; Levi M; Broliden K; Libonatti O; Wigzell H; Wahren B
    AIDS Res Hum Retroviruses; 1996 May; 12(8):705-13. PubMed ID: 8744581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding antibody to neutralizing epitope gp41 in HIV-1 subtype CRF 01_AE infection related to stage of disease.
    Srisurapanon S; Louisirirotchanakul S; Sumransurp K; Ratanasrithong M; Chuenchitra T; Jintakatkorn S; Wasi C
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):221-7. PubMed ID: 15906673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimeric synthetic peptide as antigen for immunodiagnosis of HIV-1 infection.
    Hernández M; Pozo L; Gómez I; Melchor A
    Biochem Biophys Res Commun; 2000 May; 272(1):259-62. PubMed ID: 10872836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I.
    Teeuwsen VJ; Siebelink KH; Crush-Stanton S; Swerdlow B; Schalken JJ; Goudsmit J; van de Akker R; Stukart MJ; Uytdehaag FG; Osterhaus AD
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):381-92. PubMed ID: 1692724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
    Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB
    J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of HIV-1 peptide presentation on the affinity constants of two monoclonal antibodies determined by BIAcore technology.
    Mani JC; Marchi V; Cucurou C
    Mol Immunol; 1994 Apr; 31(6):439-44. PubMed ID: 7514268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.